Search

Search Results

• 

  Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy

  Mario Masarone, Roberta Russo, Antonella Gambale, Concetta Langella, Ferdinando Carlo Sasso, Luca Fontanella, Marco Romano, Achille Iolascon, Marcello Persico

  61-70

  27-02-2014

  1913

  PDF: 1370

  HTML: 586
• 

  Efficacy of dual therapy in patients >65 years old with alanine transaminase flare during chronic hepatitis C genotype 2

  Elena Garlatti Costa, Michela Ghersetti, Silvia Grazioli, Pietro Casarin

  82-88

  20-03-2015

  1138

  PDF: 769

  HTML: 276
• 

  Etiology of newly-diagnosed cases of chronic liver disease in Southern Italy: results of a prospective multicentric study

  Antonio Ascione, Mario Masarone, Giovanni Tritto, Carmine Coppola, Cristina Mascolo, Marcello Persico, Giovanbattista Forte, Luca Fontanella, Massimo De Luca, Giovan Giuseppe Di Costanzo, the SCIROCCO Study Group

  176-181

  25-11-2013

  1754

  PDF: 1171

  HTML: 499
• 

  Use of ursodeoxycholic acid in patients with hypertransaminasemia

  Claudio Puoti, Maria Giuseppa Elmo

  141-147

  18-09-2014

  1432

  PDF: 994

  HTML: 1238
• 

  Sex differences in adverse drug reaction and liver disease

  Ombretta Para, Pietro Crispino, Nunzia Barone, Sara Macis, Laura Airasca, Paola Gnerre, Cecilia Politi

  15-22

  20-03-2018

  1939

  PDF: 828

  HTML: 443
• 

  The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis

  Sirio Fiorino, Carmela Cursaro, Stefania Lorenzini, Elisabetta Loggi, Lucia Brodosi, Laura Cattani, Andrea Cuppini, Mauro Bernardi, Pietro Andreone

  82-89

  07-03-2013

  973

  PDF: 958
• 

  The management of the patient with acute pancreatitis: from evidence to clinical practice

  Cristina Cenci, Tea Restuccia, Paola Gnerre, Irene Chiti, Laura Betti, Milena Micati, Claudio Tana

  220-245

  11-09-2017

  2609

  PDF: 1151

  HTML: 1324
• 

  HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy

  Antonio Salvio, Maria Varriale, Tito d'Errico, Gennaro De Siena, Mario Visconti

  278-281

  02-01-2012

  1021

  PDF: 673
• 

  HCV carriers with normal aminotransferase levels: normal does not always mean healthy

  Claudio Puoti

  88-92

  30-04-2013

  826

  PDF: 1138
• 

  HIV, HCV and SARS-CoV-2: friends or foes? A case report

  Elena Garlatti Costa, Cesare Mazzaro, Alessandro Grembiale, Alessandro Berto, Rita De Rosa, Silvia Grazioli, Maurizio Tonizzo

  24-09-2021

  898

  PDF: 433

  HTML: 8

• Expert consensus guideline on the diagnosis of type 1 Gaucher disease in adult patients

  Antonio De Vivo, Giovanni Marconi, Nicola Tumedei, Elisa Luicchini, Maria Chiara Finazzi, Ilaria Maria Burgo, Gian Luca Forni, Silvia Linari

  20-06-2024

  635

  PDF: 307

  SUPPLEMENTARY MATERIAL: 71

  HTML: 43